Artículos de revistas
Vaccines Under Development: Group B Streptococcus, Herpes-zoster, Hiv, Malaria And Dengue
Registro en:
Jornal De Pediatria. , v. 82, n. SUPPL. 1, p. S115 - S124, 2006.
217557
10.2223/JPED.1476
2-s2.0-33750510278
Autor
Da Silva L.J.
Richtmann R.
Institución
Resumen
Objectives: To review the current state of development of streptococcus B, herpes-zoster, HIV, malaria and dengue vaccines. These vaccines were selected both because of imminent commercial release and because of specific problems with their development. Sources of data: A review of the literature was performed by means of a MEDLINE search, on the period 1996 to 2006, for the epidemiology and immunology of these diseases, analyzing both the greatest obstacles to creating a vaccine and the current state of research, with emphasis on studies in the most advanced stages. Summary of the findings: Each of the five diseases chosen presents specific problems for vaccine development. Nevertheless, in the majority of cases these have been or are in sight of being resolved, allowing for the prediction that a safe and effective vaccine - or vaccines - will be available in the near future. Conclusions: Despite the problems faced in developing these vaccines, advances in molecular biology and immunology have made it possible to overcome most obstacles, opening up the prospects for new vaccines. Copyright © 2006 by Sociedade Brasileira de Pediatria. 82 SUPPL. 1 S115 S124 Gibbs, R.S., Schrag, S., Schuchat, A., Perinatal infections due to group B streptococci (2004) Obstet Gynecol, 104, pp. 1062-1076 Vaciloto, E., Richtmann, R., Costa, H.P.F., Kusano, E.J.U., Almeida, M.F.B., Amaro, E.R., A survey of the incidence of neonatal sepsis by group B streptococcus during a decade in a Brazilian maternity hospital (2002) Braz J Infect Dis, 6, pp. 55-62 Schuchat, A., Group B streptococcus (1999) Lancet, 353, pp. 51-56 Schrag, S., Gorwitz, R., Fultz-Butts, K., Schuchat, A., Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC (2002) MMWR Recomm Rep, 51, pp. 1-22 (2002) Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, Group B Streptococcus, , http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs02.pdf, Access: 04/03/2006 Lin, F.Y., Weisman, L.E., Azimi, P.H., Philips III, J.B., Clark, P., Regan, J., Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen (2004) J Infect Dis, 190, pp. 928-934 Baker, C.J., Kasper, D.L., Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection (1976) N Engl J Med, 294, pp. 753-756 Baker, C.J., Kasper, D.L., Group B streptococcal vaccines (1985) Rev Infect Dis, 7, pp. 458-467 Baker, C.J., Rench, M.A., Edwards, M.S., Carpenter, R.J., Hays, B.M., Kasper, D.L., Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus (1988) N Engl J Med, 319, pp. 1180-1185 Zaleznik, D.F., Rench, M.A., Hillier, S., Krohn, M.A., Platt, R., Lee, M.L., Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups (2000) Clin Infect Dis, 30, pp. 276-281 Kasper, D.L., Paoletti, L.C., Wessels, M.R., Guttormsen, H.K., Carey, V.J., Jennings, H.J., Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine (1996) J Clin Invest, 98, pp. 2308-2314 Baker, C.J., Paoletti, L.C., Wessels, M.R., Guttormsen, H.K., Rench, M.A., Hickman, M.E., Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib (1999) J Infect Dis, 179, pp. 142-150 Baker, C.J., Paoletti, L.C., Rench, M.A., Guttormsen, H.K., Edwards, M.S., Kasper, D.L., Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines (2004) J Infect Dis, 189, pp. 1103-1112 Heath, P.T., Feldman, R.G., Vaccination against group B streptococcus (2005) Expert Rev Vaccines, 4, pp. 207-218 Poland, G.A., The growing paradigm of preventing disease: Vaccines to prevent herpes zoster and pertussis in adults (2005) Ann Intern Med, 143, pp. 539-541 Donahue, J.G., Choo, P.W., Manson, J.E., Platt, R., The incidence of herpes zoster (1995) Arch Intern Med, 155, pp. 1605-1609 Helgason, S., Petursson, G., Gudmundsson, S., Sigurdsson, J.A., Prevalence of postherpetic neuralgia after a first episode of herpes zoster: Prospective study with long term follow up (2000) BMJ, 321, pp. 794-796 Di Luzio Paparatti, U., Arpinelli, F., Visona, G., Herpes zoster and its complication in Italy: An observational survey (1999) J Infect, 38, pp. 116-120 Chidiac, C., Bruxelle, J., Daures, J.P., Hoang-Xuan, T., Morel, P., Leplege, A., Characteristics of patients with herpes zoster on presentation to practitioners in France (2001) Clin Infect Dis, 33, pp. 62-69 Hodson, A.H., Epidemiology of shingles (1991) J R Soc Med, 84, p. 184 Mounsey, A.L., Matthew, L.G., Slawson, D.C., Herpes zoster and postherpetic neuralgia: Prevention and management (2005) Am Fam Physician, 72, pp. 1075-1080 Thomas, S.L., Wheeler, J.G., Hall, A.J., Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study (2002) Lancet, 360, pp. 678-682 Wood, M.J., Kay, R., Dworkin, R.H., Soong, S.J., Whitley, R.J., Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials (1996) Clin Infect Dis, 22, pp. 341-347 Tyring, S.K., Beutner, K.R., Tucker, B.A., Anderson, W.C., Crooks, R.J., Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older (2000) Arch Fam Med, 9, pp. 863-869 Jackson, J.L., Gibbons, R., Meyer, G., Inouye, L., The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis (1997) Arch Intern Med, 157, pp. 909-912 Oxman, M.N., Levin, M.J., Johnson, G.R., Schmader, K.E., Straus, S.E., Gelb, L.D., A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults (2005) N Engl J Med, 352, pp. 2271-2284 Campion, E.W., The oldest old (1994) N Engl J Med, 330, pp. 1819-1820 Chaturvedi, U.C., Shrivastava, R., Nagar, R., Dengue vaccines: Problems and prospects (2005) Indian J Med Res, 121, pp. 639-652 Damonte, E.B., Pujol, C.A., Coto, C.E., Prospects for the therapy and prevention of dengue virus infections (2004) Adv Virus Res, 63, pp. 239-285 Schlagenhauf, P., Malaria: From prehistory to present (2004) Infect Dis Clin North Am, 18, pp. 189-205 Greenwood, B., Malaria vaccines. Evaluation and implementation (2005) Acta Trop, 95, pp. 298-304 Breman, J.G., Alilio, M.S., Mills, A., Conquering the intolerable burden of malaria: What's new, what's needed: A summary (2004) Am J Trop Med Hyg, 71, pp. 1-15 Moorthy, V.S., Good, M.F., Hill, A.V., Malaria vaccine developments (2004) Lancet, 363, pp. 150-156 Good, M.F., Stanisic, D., Xu, H., Elliott, S., Wykes, M., The immunological challenge to developing a vaccine to the blood stages of malaria parasites (2004) Immunol Rev, 201, pp. 254-267 Engwerda, C.R., Good, M.F., Interactions between malaria parasites and the host immune system (2005) Curr Opin Immunol, 17, pp. 381-387 Good, M.F., Xu, H., Wykes, M., Engwerda, C.R., Development and regulation of cell-mediated immune responses to the blood stages of malaria: Implications for vaccine research (2005) Annu Rev Immunol, 23, pp. 69-99 Good, M.F., Vaccine-induced immunity to malaria parasites and the need for novel strategies (2005) Trends Parasitol, 21, pp. 29-34 Webster, D., Hill, A.V., Progress with new malaria vaccines (2003) Bull World Health Organ, 81, pp. 902-909 Greenwood, B.M., Bojang, K., Whitty, C.J., Targett, G.A., Malaria (2005) Lancet, 365, pp. 1487-1498 Heppner Jr., D.G., Kester, K.E., Ockenhouse, C.F., Tornieporth, N., Ofori, O., Lyon, J.A., Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: Progress at the Walter Reed Army Institute of Research (2005) Vaccine, 23, pp. 2243-2250 Ballou, W.R., Arevalo-Herrera, M., Carucci, D., Richie, T.L., Corradin, G., Diggs, C., Update on the clinical development of candidate malaria vaccines (2004) Am J Trop Med Hyg, 71, pp. 239-247 Hill, A.V., Pre-erythrocytic malaria vaccines: Towards greater efficacy (2006) Nat Rev Immunol, 6, pp. 21-32 Vernick, K.D., Waters, A.P., Genomics and malaria control (2004) N Engl J Med, 351, pp. 1901-1904